Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats

Clinics

Volumn 63, Issue 6, 2008, Pages 807-813

  Habib, Shafina Hanim Mohd ^a   Makpol, Suzana ^a   Hamid, Noor Aini Abdul ^a   Das, Srijit ^a   Ngah, Wan Zurinah Wan ^a   Yusof, Yasmin Anum Mohd ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Chemopreventive; Ginger; Inflammatory markers; NF B; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ETHIONINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; GINGER; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ETHIONINE; GINGER; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NF-KAPPA B; PLANT EXTRACTS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57349177876     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000600017     Document Type: Article

References (30)

1. Ohshima H, Bartsc H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res. 1994;305: 253-64.
2. Ohshima H, Tatemicho M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem Biophys. 2003;417:3-11.
3. Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14:433-9.
4. Marx J. Inflammation and cancer: the link grows stronger. Science. 2004;306:966-68.
5. Lawrence T. Inflammation and cancer: a failure of resolution? Trends in Pharmacol Sci. 2007;28:162-65.
6. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-67.
7. Aggarwal BB. Nuclear factor-κB:The enemy within. Cancer Cell. 2004;6:203-08.
8. Aggarwal BB. Signaling pathways of TNF superfamily: a double-edged sword. National Review Immunology. 2003;3:745-56.
9. Balkwill F. Tumor Necrosis Factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13:135-41.
10. Lin A, Karin M. NF-kappaB in cancer: a marked target. Semin Cancer Biol. 2003; 13:107-14.
11. Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A, Zamora A. The transcription factor kappa B and cancer. Clinical Oncology. (R Coll Radiol) 2007;19:154-61.
12. Surh, YJ. Cancer chemoprevention with dietary phytochemical. Nat Rev Cancer. 2003;3:768-80.
13. Kim SO, Chun KS, Kundu. J, Surh YJ. Inhibitory effects pg 6-gingerol on PMA-induced COX-2 expression and activation of NFκB and p38 MAPK in skin mouse. Biofactors. 2004;21:27-31.
14. Afzal M, Al-Hadidi D, Menon M, Pesek J, Dhami MS. Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact. 2001;18: 159-90.
15. Jeyakumar SM, Nalini N, Menon VP. Antioxidant activity of ginger (Zingiber officinale) in rats fed a high fat diet. Med Sci Res. 1999;27:341-44.
16. Shukla Y, Singh M. Cancer preventive properties of ginger: A brief review. Food Chem Toxicol. 2007;45:683-90.
17. Hudson, E.A., Fox, L.H., Luckett, J.C.A & Manson, M.M.. Ex vivo cancer chemoprevention research possibilities. Environmental Toxicology and pharmacology. 2006;21:204-14.
18. Huang S, DeGuzman A, Bucana CD, Fidler IJ. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res. 2000;6:2573-81.
19. Coppola G, Novo S. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch Med Res. 2007;38:479-88.
20. Nonn L, Duong D, Peehl DM: Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis. 2007;28:1188-96.
21. Kim EC, Min, JK, Kim TY, Lee SJ, Yang HO, Han S, et al. Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo Biochem Biophys Res Commun. 2005;335:300-8.
22. Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J, et al. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complementary and Alternative Medicine. 2007;20:7-44.
23. Akhurst B, Croager EJ, Farley-Roche, C.A, Ong JK, Dumble ML, Knight B & Yeoh GC. 2001. A modified Choline-Deficient, Ethionine Supplemented Diet protocol effectively induces oval cells in mouse liver. Hepatology 34:519-22.
24. Bharti AC, Aggarwal BB. Nuclear factor-κB and cancer: Its role in prevention and therapy. Biochem Pharmacol. 2002;64:883-88.
25. Arsura M, Cavin LG. Nuclear factor- κB and liver carcinogenesis. Cancer Lett. 2005;229:157-69.
26. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-6.
27. Park KK, Chun KS, Lee SS, Surh YJ. Inhibitory effect of [6] -gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 1998;129:139-44.
28. Aggarwal BB, Shishodia S. Molecular targets of dietary for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397-21.
29. Kundu JK, Surh YJ. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. Mutat Research. 2005;591:123-46.
30. Padifico F, Leornadi A. NF-kappaB in solid tumors. Biochem Pharmacol. 2006; 72:1142-52.